REINREUDE MULTI-PURPOSE TREATMENT

Manufacturer
Jiangxi Hemei Pharmaceutical Co., Ltd
Effective date
2025-01-08
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 20:43:23

Label at a glance#

ProductREINREUDE MULTI-PURPOSE TREATMENT
Active ingredientTOLNAFTATE
Label structure13 sections

Dosage and administration

For athlete's foot and ring worm: use daily for 4 weeks. Clean the affected area and dry thoroughly. Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Supervise children in the use of this product. This product is not effective for the treatment of ring worm of the scalp or nails. For athlete's foot: pay special attention to spaces between the toes, we...

Storage and handling

Store at room temperature 15-30℃ (59-86 F)

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Tolnaftate 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Use

INDICATIONS & USAGE SECTION

Cures most Athlete's Foot (Tinea Pedis) and Ringworm (Tinea Corporis). Relieves itching, scaling, cracking, burning, redness, sorenes, and irritation and discomfort. Helps prevent most athlete's foot (dermatophytosis) with daily use.

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

on children under 2 years of age unless directed by a doctor.

When Using

OTC - WHEN USING SECTION

avoid contact with eyes.

Stop Use

OTC - STOP USE SECTION

irritation occurs, there is no improvement within 4 weeks (for athlete's foot and ringworm).

Ask Doctor

OTC - ASK DOCTOR SECTION

irritation occurs, there is no improvement within 4 weeks (for athlete's foot and ringworm).

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For athlete's foot and ring worm:
use daily for 4 weeks. Clean the affected area and dry thoroughly.

Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Supervise children

in the use of this product. This product is not effective for the treatment of ring worm of the scalp or nails. For athlete's foot: pay special attention to spaces between the toes, wear well-fitting, ventil ated shoes, and change shoes and socks at least once daily. To prevent athlete's foot, apply once or twice daily (morning and/or night). Apply to skin around the nail and cuticle.

Other information

STORAGE AND HANDLING SECTION

Store at room
temperature 15-30℃ (59-86 F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, euphorbia hirta whole, glycerin, hydracrylic acid, pseudolarix amabilis bark, resorcinol, etc.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84010-065REINREUDE MULTI-PURPOSE TREATMENT (TOLNAFTATE 1% MULTI-PURPOSE TREATMENT) LIQUID [JIANGXI HEMEI PHARMACEUTICAL CO., LTD]1Unmatched20250109_2b2c8a4f-467a-c731-e063-6294a90ad962.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84010-06584010-065-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4a4a6f1e-7835-deef-e063-6294a90a85a32b2c8a4f-467a-c731-e063-6294a90ad9622026-02-08WarningsExact identifier
spl set id: 2b2c8a4f-467a-c731-e063-6294a90ad962

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.